Diadema Partners »

Passage Bio shares owned by Diadema Partners

Quarter-by-quarter ownership of Passage Bio (PASG) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Passage Bio

Tip: Access up to 7 years of quarterly data

All positions including Passage Bio held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Passage Bio by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $153k 20k 7.85

More positions owned by Diadema Partners

United Therapeutics Corporation Put Option (UTHR)
Vertex Pharmaceuticals Incorporated (VRTX)
Viking Therapeutics (VKTX)
Capricor Therapeutics Com New Call Option (CAPR)
Abivax Sa Sponsored Ads (ABVX)
Liquidia Corporation Com New Call Option (LQDA)
Revolution Medicines (RVMD)
Apogee Therapeutics Call Option (APGE)
Bridgebio Pharma Note 1.750% 3/0
Incyte Corporation Put Option (INCY)
Kodiak Sciences Put Option (KOD)
Cytokinetics Com New Call Option (CYTK)
Johnson & Johnson (JNJ)
Cogent Biosciences (COGT)
Merck & Co Put Option (MRK)

View all positions for Diadema Partners

Top funds holding Passage Bio

Lynx1 Capital Management
Vestal Point Capital
Renaissance Technologies
Eversept Partners
Vanguard Group
Vanguard Capital Management
Yiheng Capital
Erste Asset Management GmbH
Ikarian Capital
Geode Capital Management
BlackRock
UBS Group
Acadian Asset Management
Verdad Advisers
Diadema Partners

View all funds holding Passage Bio